This study will test and modify rules that can identify children at low risk of having complications of fever and neutropenia after cancer chemotherapy and who will be eligible for early discharge and outpatient treatment. Immune function blood tests will also be assessed to see if they add value to the rule which is based on patient factors.
Peter MacCallum Cancer Centre
National Health & Medical Research Council
Prof Karin Thursky, Infectious Diseases Physician
Dr Gab Haeusler
Infectious Diseases Fellow
Email: [email protected]